IMMUCELL CORP /DE/ — Director's Dealing 2014

Nov 26, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2014-11-25

Reporting Person: ROTHSCHILD JONATHAN E (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-25	Common Stock, par value $0.10 per share	P	1000.0000	$4.7900	Acquired	514436.0000	Direct
2014-11-25	Common Stock, par value $0.10 per share	P	500.0000	$4.7900	Acquired	514936.0000	Direct
2014-11-26	Common Stock, par value $0.10 per share	P	300.0000	$4.8700	Acquired	515236.0000	Direct
2014-11-26	Common Stock, par value $0.10 per share	P	300.0000	$4.9000	Acquired	515536.0000	Direct

Footnotes

F1: These shares were acquired by Arterio Inc., a corporation owned solely by Mr. Rothschild.

F2: This figure includes 217,055 shares of common stock held by Arterio Inc., a corporation owned solely by Mr. Rothschild, and 39,555 shares held by the estate of Mr. Rothschild's parents. Mr. Rothschild is the executor of his parents' estate and is a one-third beneficiary of that estate. The distribution of the assets of that estate has not yet been resolved.